−0.280EUR
−4.44 MEUR
15.10 MEUR
13.70 M
About OPTOMED PLC
Sector
Industry
CEO
Juho-Pekka Himberg
Website
Headquarters
Oulu
Employees (FY)
114
Founded
2004
ISIN
FI4000410881
FIGI
BBG00QT999F6
Optomed Oyj engages in the provision of handheld fundus cameras and eye-screening solutions. It operates through the Devices and Software segments. The Devices segment develops, commercializes and manufactures handheld fundus cameras that are suitable for any clinic for screening of various eye diseases, such as diabetic retinopathy, gakucoma and Age Related Mascular Degeneration. The Software segment develops and commercializes screening software for diabetic retinopathy and cancer screening for healthcare organizations. The company was founded by Seppo Henrik Kopsala on December 20, 2004 and is headquartered in Oulu, Finland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of OPTOMED is 4.185 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange OPTOMED PLC stocks are traded under the ticker OPTOMED.
OPTOMED PLC is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
OPTOMED stock is 1.82% volatile and has beta coefficient of 1.38. Check out the list of the most volatile stocks — is OPTOMED PLC there?
OPTOMED earnings for the last quarter are −0.02 EUR per share, whereas the estimation was −0.02 EUR resulting in a 0% surprise. The estimated earnings for the next quarter are −0.10 EUR per share. See more details about OPTOMED PLC earnings.
OPTOMED PLC revenue for the last quarter amounts to 4.20 M EUR despite the estimated figure of 4.20 M EUR. In the next quarter revenue is expected to reach 3.70 M EUR.
Yes, you can track OPTOMED PLC financials in yearly and quarterly reports right on TradingView.
OPTOMED stock has fallen by 1.76% compared to the previous week, the month change is a 2.45% rise, over the last year OPTOMED PLC has showed a 0.36% increase.
OPTOMED net income for the last quarter is −1.53 M EUR, while the quarter before that showed −439.00 K EUR of net income which accounts for −248.52% change. Track more OPTOMED PLC financial stats to get the full picture.
Today OPTOMED PLC has the market capitalization of 74.39 M, it has increased by 1.70% over the last week.
No, OPTOMED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OPTOMED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPTOMED PLC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 114.00 employees. See our rating of the largest employees — is OPTOMED PLC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPTOMED PLC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPTOMED PLC stock shows the buy signal. See more of OPTOMED PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on OPTOMED PLC future price: according to them, OPTOMED price has a max estimate of 7.50 EUR and a min estimate of 3.30 EUR. Read a more detailed OPTOMED PLC forecast: see what analysts think of OPTOMED PLC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPTOMED PLC EBITDA is −1.80 M EUR, and current EBITDA margin is −18.21%. See more stats in OPTOMED PLC financial statements.